In the BioHarmony Drug Report Database
Cefotetan
Cefotan, Cefotetan (cefotetan) is a small molecule pharmaceutical. Cefotetan was first approved as Cefotan on 1985-12-27. It is used to treat abscess, bacterial infections, bacterial skin diseases, bacteroides infections, and clostridium infections amongst others in the USA.
Trade Name
|
Cefotan, Cefotetan |
|---|---|
Common Name
|
cefotetan |
ChEMBL ID
|
CHEMBL474579 |
Indication
|
abscess, bacterial infections, bacterial skin diseases, bacteroides infections, clostridium infections, escherichia coli infections, fusobacterium infections, gonorrhea, haemophilus infections, human bites, infectious bone diseases, infectious pregnancy complications, klebsiella infections, peritonitis, proteus infections, respiratory tract infections, soft tissue infections, staphylococcal infections, streptococcal infections, surgical wound infection, urinary tract infections |
Drug Class
|
Cephalosporins |
Image (chem structure or protein)